Influenza vaccine
Vaccine against influenza
Ratings
0
Nobody has rated this yet. Be the first!
Subject of
16
Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6-23 months of age.
Influenza vaccine-induced human bone marrow plasma cells decline within a year after vaccination
Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells
Modelling the risk-benefit impact of H1N1 influenza vaccines
Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004.
Effectiveness of influenza vaccine in reducing influenza-associated hospitalizations and deaths among the elderly population; Lazio region, Italy, season 2016-2017
Update: Influenza Activity - United States and Worldwide, May 19-September 28, 2019, and Composition of the 2020 Southern Hemisphere Influenza Vaccine
Influenza activity - United States, 2014-15 season and composition of the 2015-16 influenza vaccine
Reactogenicity of two 2010 trivalent inactivated influenza vaccine formulations in adults
Safety and immunogenicity of a recombinant M2e-flagellin influenza vaccine (STF2.4xM2e) in healthy adults
Lists
0